Dainippon Sumitomo looking for new Sunovion CEO following Iwicki departure
This article was originally published in Scrip
Executive Summary
Mark Iwicki, the president and CEO of Dainippon Sumitomo Pharmaceuticals' (DSP) US subsidiary Sunovion Pharmaceuticals, has resigned his positions with the company.